Materials • Major Chemicals
$2.52 ▼ -0.16
(-5.97%)
MKT CAP: $62.9M • VOL: 61.9K
52W L $2 52W H $10
CITR // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.4M | $808.4K | $520.6K |
| YoY Revenue Growth % | +194.6% | +55.3% | — |
| Gross Profit | $530.7K | $152.9K | — |
| Gross Margin % | 22.3% | 18.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$16.5M | -$5.3M | -$10.1M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$36.8M | -$6.9M | -$10.1M |
| EBITDA (Normalized) | -$16.3M | -$5.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$5.9M | -$1.9M | -$1.2M |
| Capital Expenditures (CapEx) | $194.0K | $0 | — |
| Free Cash Flow (FCF) | -$6.1M | -$1.9M | -$1.2M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $6.3M | $775.1K | — |
| Total Debt (Short + Long Term) | — | $0 | — |
| Total Stockholders' Equity | $11.3M | $3.3M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR CITR.